Reuters logo
BRIEF-Kitov announces initiation of formal investigation by Israeli Securities Authority
February 7, 2017 / 4:22 PM / 10 months ago

BRIEF-Kitov announces initiation of formal investigation by Israeli Securities Authority

Feb 7 (Reuters) - Kitov Pharmaceuticals Holdings Ltd

* Kitov announces initiation of formal investigation by Israeli Securities Authority

* Israeli Securities Authority has begun a formal investigation into company’s public disclosures around its lead drug candidate, KIT-302

* Investigation is in its initial stages, and Kitov’s officers are cooperating fully

* Company continues to move forward toward filing of our new drug application for KIT-302 with FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below